Deltanoid Pharmaceuticals, Inc. today announced the appointment of former Genzyme/Sanofi renal head, Douglas Jermasek as its new Chief Executive Officer. Co-founder Hector F DeLuca, PhD, MD, DSC will continue as Chairman of the Board of Directors and assume the responsibilities of President and Chief Operating Officer. Co-founder Margaret Clagett-Dame, PhD will continue in her role as Executive Vice President. Read the full WisBusiness story here.
.@virent_inc leader sees potential for collaboration with #dairy and #paper industries. https://loom.ly/ciFqnzg via @wisbusiness #startup
Inside #Wisconsin: Taking off: #Aviation #innovation continues to fly high in Wisconsin. https://loom.ly/lLmZXr4 via @tstillwtc
A nanomaterial that mimics proteins could be basis for new neurodegenerative disease treatments. via @uwmadison #university #Wisconsin #innovation
Nanomaterial that mimics proteins could be basis for new neurodegenerative disease treatments
The work centers around altering the interaction between two proteins that are believed to be involved in setting ...
loom.ly
.@wedcnews board approves up to $15.5M in tax credits for a @kikkomankitchen expansion in #Wisconsin. https://loom.ly/q7lhKkA via @wisbusiness #busdev
Maneesh Arora, who leads the #cancer-fighting Elephas, will speak 6/6 at the #Wisconsin Entrepreneurs' Conference.
Learn more and register: https://loom.ly/O4Lq-Os #startup #leadership
#Wisconsin has been selected for a $62.4 million federal grant through the @EPA’s #Solar for All initiative. https://loom.ly/M4MQVwA via @wisbusiness #energy